CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Diomed Holdings, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Diomed Holdings, Inc.
1 Dundee Park
Andover, MA  01810  United States Ticker: DIOMQDIOMQ

On 10/27/2011, the Company's bankruptcy case (#08-40750) was closed in the U.S. Bankruptcy Court for the District of Massachusetts
On 6/18/08, the Company's good assets & Diomed, Inc. were sold to AngioDynamics, Inc.
This company is no longer actively traded on any major stock exchange.

Business Summary
Diomed Holdings, Inc. (Diomed) develops and commercializes minimally invasive medical procedures that employ its laser technologies and associated disposable products. Using its technology, the Company focuses on endovenous laser treatment (EVLT) of varicose veins. The Company also develops and markets lasers and disposable products for photodynamic therapy (PDT) cancer procedures and products for other clinical applications, including dental and general surgical procedures. Diomed’s business is primarily done through its wholly owned subsidiaries, Diomed, Inc. and Diomed, Ltd. In March 2008, the Company announced that it, together with its wholly owned subsidiary, Diomed, Inc., filed a voluntary petition under Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the District of Massachusetts, Western Division.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
IRA CQ
Score
Moody's
Rating
Fitch
Rating
DBRS
Rating
Morningstar
Rating
-Yes-------

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/200712/31/2006YesYesYes--

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board GeoffreyJenkins 56 1/13/2003 2/14/2002
President, Chief Executive Officer, Director James A.Wylie 68 1/14/2003 1/14/2003
Chief Financial Officer, Director David B.Swank 49 9/1/2003 3/1/2003
8 additional Officers and Directors records available in full report.

Business Names
Business Name
Diomed, Ltd.
DIOMQ

General Information
Number of Employees: 100 (As of 12/31/2006)
Outstanding Shares: 30,318,331 (As of 11/13/2007)
Shareholders: 307
Stock Exchange: OTC
Federal Tax Id: 841480636


Copyright © 2019 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, August 18, 2019